Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014
|出版日||ページ情報||英文 556 Pages
|ペプチドによる癌治療：世界の市場およびパイプラインの分析 Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014|
|出版日: 2014年08月01日||ページ情報: 英文 556 Pages||
The conventional methods developed to prevent and eradicate the prevalence of cancer have achieved limited success in cancer treatment. These methods are confined to low specificity, safety and large number of side effects, which prompted the researchers to look for a better solution. It has been discovered that peptides can be used for effective and viable treatment of cancer without having disadvantages of conventional methods. The quintessential for using peptide cancer therapeutics is that they have high specificity, safety and efficacy which is not provide by therapeutics available in market.
The completion of human genome sequencing has helped in the research and development of peptide cancer therapeutics. The data allowed the researchers to look deep into the root cause of cancer hidden in human genome. This has allowed targeting cancer cells with high accuracy; thus, increasing the probability of treatment with high success rates. Using this data several novel molecules are being developed, which will have higher stability, effective delivery and minimal or no side-effects.
Peptide cancer therapeutics has edge in treating rare type of cancers. Conventional approaches of cancer treatments are unable to treat them successfully. Sometimes these approaches cannot be used due to unspecificity or they are not effective at all. For instance, brain cancer is a rare type of cancer that falls in this category. Brain is a very sensitive organ, to protect itself from unwanted substances it has developed blood brain barrier. It very difficult to breach, here conventional cancer therapeutics faces a sever challenge. On the other hand, peptide cancer therapeutics is able to overcome this barrier. Markets for these medicines have a huge potential and many medicines are under various phases of clinical trials
Peptide cancer therapies hold a promising future for the treatment of cancer. Various clinical trials studies have demonstrated the fact that the potential of peptide based drugs to prevent and eradicate cancer is far effective than conventional cancer therapy. In some studies, it has been found that combinatorial therapies will be more effective than individual methods. In combinatorial therapy, both conventional and peptide based cancer therapeutics are used for the treatment.
"Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014" Report Highlight: